EMG
GHDX

Ellington Management Group’s Genomic Health, Inc. GHDX Stock Holding History

Ellington Management Group’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-9,500
Closed -$278K – 826
2013
Q4 		$278K Buy
+9,500
New +$301K 0.1% 342

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ICM
IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return

Ellington Management Group's GHDX Position: Q1 2014 in Review

Ellington Management Group sold out of Genomic Health, Inc. (GHDX) in Q1 2014, closing a stake of 9,500 shares — an estimated $278K sold.

Ellington Management Group first reported a position in GHDX in Q4 2013 and held it in 1 quarter. The position peaked at $278K in Q4 2013. 101 funds tracked by Wall St. Rank hold GHDX as of Q1 2014.

  • Ellington Management Group reported no remaining Genomic Health, Inc. position as of Q1 2014 after selling out during the quarter.
  • Ellington Management Group sold 9,500 Genomic Health, Inc. shares in Q1 2014, an estimated $278K.
  • Ellington Management Group first reported a position in Genomic Health, Inc. in Q4 2013 and held it in 1 quarter.
  • Ellington Management Group's Genomic Health, Inc. position peaked at $278K in Q4 2013.
  • 101 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2014.

Based on Ellington Management Group's 13F filing for Q1 2014, filed 15 May 2014.